Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by ALX Oncology

ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology Announces First Patient Dosed in Phase 2 Investigator-Sponsored Trial of Evorpacept in Patients with Ovarian Cancer
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology and Quantum Leap Healthcare Collaborative™ Announce First Patient Dosed in the I-SPY-P1 TRIAL in Breast Cancer
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology Announces First Patient Dosed in ASPEN-07, a Phase 1 Study of Evorpacept for the Treatment of Patients with Urothelial Cancer
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2023
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology Announces Initial Data from ASPEN-05 Study of Evorpacept in Combination with Azacitidine and Venetoclax, Demonstrating Tolerability and Preliminary Activity in Patients with Acute Myeloid Leukemia
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology Appoints Scott Garland to its Board of Directors
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology to Present New Clinical Data on Evorpacept in Acute Myeloid Leukemia at 64th ASH Annual Meeting
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology Announces Upcoming Investor Conference Participation
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology Enters $100 Million Loan Facility Agreement with Oxford Finance and Silicon Valley Bank to Support Ongoing Development of Evorpacept
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
ALX Oncology Announces Trials in Progress Abstracts Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.